JUL 15, 2026 · JOURNAL ARTICLE
CRISPR-ENABLED ANTIMICROBIAL STRATEGIES: REDEFINING PRECISION THERAPY AGAINST MULTIDRUG RESISTANT PATHOGENS
Genetics and Molecular Research
This is a narrative review synthesizing mechanistic and preclinical evidence on CRISPR antimicrobials; it raises the therapeutic potential of the platform but does not report original clinical data, RCT results, or human efficacy outcomes.
Study details
DesignNarrative literature review